These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 20127023)
1. KBH-A42, a histone deacetylase inhibitor, inhibits the growth of doxorubicin-resistant leukemia cells expressing P-glycoprotein. Kang MR; Lee K; Kang JS; Lee CW; Lee KH; Kim JH; Yang JW; Kim BG; Han G; Kang JS; Park SK; Kim HM Oncol Rep; 2010 Mar; 23(3):801-9. PubMed ID: 20127023 [TBL] [Abstract][Full Text] [Related]
2. A novel delta-lactam-based histone deacetylase inhibitor, KBH-A42, induces cell cycle arrest and apoptosis in colon cancer cells. Kang MR; Kang JS; Han SB; Kim JH; Kim DM; Lee K; Lee CW; Lee KH; Lee CH; Han G; Kang JS; Kim HM; Park SK Biochem Pharmacol; 2009 Sep; 78(5):486-94. PubMed ID: 19445901 [TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells and in vivo endotoxemia model. Choi Y; Park SK; Kim HM; Kang JS; Yoon YD; Han SB; Han JW; Yang JS; Han G Exp Mol Med; 2008 Oct; 40(5):574-81. PubMed ID: 18985016 [TBL] [Abstract][Full Text] [Related]
4. Chabamide induces cell cycle arrest and apoptosis by the Akt/MAPK pathway and inhibition of P-glycoprotein in K562/ADR cells. Ren J; Xu Y; Huang Q; Yang J; Yang M; Hu K; Wei K Anticancer Drugs; 2015 Jun; 26(5):498-507. PubMed ID: 25714087 [TBL] [Abstract][Full Text] [Related]
5. Superior activity of a new histone deacetylase inhibitor (ZYJ-34c) in inhibiting growth of human leukemia cells by inducing p21WAF1 expression and cell cycle arrest. Yang H; Xu W; Li Y; Lan P; Zhang J; Zhang Y; Zhang C Anticancer Drugs; 2014 Aug; 25(7):767-77. PubMed ID: 24686006 [TBL] [Abstract][Full Text] [Related]
6. Suberoylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P-glycoprotein-expressing cells. Ruefli AA; Bernhard D; Tainton KM; Kofler R; Smyth MJ; Johnstone RW Int J Cancer; 2002 May; 99(2):292-8. PubMed ID: 11979447 [TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of KBH-A42, a novel histone deacetylase inhibitor, in human leukemia and bladder cancer cell lines. Kang MR; Kang JS; Yang JW; Kim BG; Kim JA; Jo YN; Lee K; Lee CW; Lee KH; Yun J; Kim HM; Han G; Kang JS; Park SK Oncol Lett; 2012 Jan; 3(1):113-118. PubMed ID: 22740865 [TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitor, Romidepsin (FK228) inhibits endometrial cancer cell growth through augmentation of p53-p21 pathway. Li LH; Zhang PR; Cai PY; Li ZC Biomed Pharmacother; 2016 Aug; 82():161-6. PubMed ID: 27470351 [TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells. Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377 [TBL] [Abstract][Full Text] [Related]
10. NBM-T-BBX-OS01, Semisynthesized from Osthole, Induced G1 Growth Arrest through HDAC6 Inhibition in Lung Cancer Cells. Pai JT; Hsu CY; Hua KT; Yu SY; Huang CY; Chen CN; Liao CH; Weng MS Molecules; 2015 May; 20(5):8000-19. PubMed ID: 25946558 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of the histone deacetylase inhibitor (S)-2 against LNCaP and PC3 human prostate cancer cells. Laurenzana A; Balliu M; Cellai C; Romanelli MN; Paoletti F PLoS One; 2013; 8(3):e58267. PubMed ID: 23469273 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells. Rokhlin OW; Glover RB; Guseva NV; Taghiyev AF; Kohlgraf KG; Cohen MB Mol Cancer Res; 2006 Feb; 4(2):113-23. PubMed ID: 16513842 [TBL] [Abstract][Full Text] [Related]
13. A novel histone deacetylase inhibitor, CG0006, induces cell death through both extrinsic and intrinsic apoptotic pathways. Hwang JJ; Kim YS; Kim MJ; Jang S; Lee JH; Choi J; Ro S; Hyun YL; Lee JS; Kim CS Anticancer Drugs; 2009 Oct; 20(9):815-21. PubMed ID: 19644355 [TBL] [Abstract][Full Text] [Related]
14. A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells. Yim D; Singh RP; Agarwal C; Lee S; Chi H; Agarwal R Cancer Res; 2005 Feb; 65(3):1035-44. PubMed ID: 15705905 [TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitor trichostatin A inhibits the growth of bladder cancer cells through induction of p21WAF1 and G1 cell cycle arrest. Li GC; Zhang X; Pan TJ; Chen Z; Ye ZQ Int J Urol; 2006 May; 13(5):581-6. PubMed ID: 16771729 [TBL] [Abstract][Full Text] [Related]
17. Ginsenoside 20(s)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells. Liu ZH; Li J; Xia J; Jiang R; Zuo GW; Li XP; Chen Y; Xiong W; Chen DL Chem Biol Interact; 2015 Dec; 242():227-34. PubMed ID: 26482938 [TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib. Zhang GS; Liu DS; Dai CW; Li RJ Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520 [TBL] [Abstract][Full Text] [Related]
19. 2-D gel electrophoresis-based proteomic analysis reveals that ormeloxifen induces G0-G1 growth arrest and ERK-mediated apoptosis in chronic myeloid leukemia cells K562. Pal P; Kanaujiya JK; Lochab S; Tripathi SB; Bhatt ML; Singh PK; Sanyal S; Trivedi AK Proteomics; 2011 Apr; 11(8):1517-29. PubMed ID: 21360677 [TBL] [Abstract][Full Text] [Related]
20. A novel anthracene derivative, MHY412, induces apoptosis in doxorubicin-resistant MCF-7/Adr human breast cancer cells through cell cycle arrest and downregulation of P-glycoprotein expression. De U; Chun P; Choi WS; Lee BM; Kim ND; Moon HR; Jung JH; Kim HS Int J Oncol; 2014 Jan; 44(1):167-76. PubMed ID: 24190517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]